Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-17 to 2023-06-16
Current total value of award: $778389
Description: PRECLINICAL PREVENT CANCER PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS  TO TITLE: TARGETING THE RXR PATHWAY FOR THE PREVENTION OF TRIPLE-NEGATIVE BREAST CANCER